Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
INCY compared with NBIX: revenue, margins and what each company keeps, and the suppliers and customers both name
INCY
Incyte Corp
Change
Mkt cap
Revenue
Revenue
NBIX
Neurocrine Biosciences Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
INCY
Incyte Corp
vs
NBIX
Neurocrine Biosciences Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
INCY
Incyte Corp
Change
120.04
▼
−0.29%
· post 120.07
Mkt cap
$24.5B
Revenue
$1.6B
Q3 FY26
Revenue
$5.1B
FY25
NBIX
Neurocrine Biosciences Inc
Change
145.87
▼
−0.16%
· post 154.00
Closed
Nov 2 '26
Mkt cap
$14.9B
Revenue
$1.1B
Q3 FY26
Revenue
$2.9B
FY25
vs
Compare
Closed
Nov 2 '26
INCY
Incyte Corp
vs
NBIX
Neurocrine Biosciences Inc
120.04
▼
−0.29%
post 120.07
Price
145.87
▼
−0.16%
post 154.00
$24.5B
Mkt cap
$14.9B
Q3 FY26
$1.6B
Revenue
$1.1B
Q3 FY26
FY25
$5.1B
Revenue
$2.9B
FY25
Change
Change
INCY
120.04
▼
−0.29%
vs
NBIX
145.87
▼
−0.16%
Closed
Nov 2 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
INCY: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
INCY, solid
NBIX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only INCY
5
MGNX
Macrogenics
supplier
PRLD
Prelude Therapeutics
supplier
AGEN
Agenus
supplier
—
ARIAD/Takeda
unlisted
supplier
1 more · INCY chain
›
Shared
0
No shared counterparties.
Only NBIX
9
ABBV
AbbVie
supplier
XENE
Xenon Pharmaceuticals
supplier
KRC
Kilroy Realty
supplier
MAZE
Maze Therapeutics
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
5 more · NBIX chain
›